Cargando…
Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients
We aimed to validate the liver fibrosis index FIB-4 as a model for risk stratification of hepatocellular carcinoma development in predominantly non-Asian patients with chronic hepatitis B infection seen at a tertiary referral center in Germany. We retrospectively analyzed 373 adult patients with chr...
Autores principales: | Demir, Münevver, Grünewald, Friederike, Lang, Sonja, Schramm, Christoph, Bowe, Andrea, Mück, Vera, Kütting, Fabian, Goeser, Tobias, Steffen, Hans-Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044885/ https://www.ncbi.nlm.nih.gov/pubmed/27661015 http://dx.doi.org/10.1097/MD.0000000000004602 |
Ejemplares similares
-
NAFLD and cardiovascular diseases: a clinical review
por: Kasper, Philipp, et al.
Publicado: (2020) -
Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
por: Kim, Seung Up, et al.
Publicado: (2016) -
FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning
por: Ding, Yuping, et al.
Publicado: (2023) -
Using vibration controlled transient elastography and FIB-4 to assess liver cirrhosis in a hepatitis C virus infected population
por: Saleem, Nabil, et al.
Publicado: (2021) -
The outcome of the HCC patients underwent ALPPS: Retrospective study
por: Peng, Chihan, et al.
Publicado: (2019)